Medication info
Akande Tablet 8 mg (Candesartan Cilexetil)

Akande Tablet 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Hanin Pharmaceutical Co., Ltd.
Appearance
Light pink, round, biconvex tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201704761 · Approved 2017.06.26 · Insurance code 657203170

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: Candesartan cilexetil 8 ∼ 16 mg orally once daily is recommended as the initial and maintenance dose. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled with this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Pediatric patients: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Hanin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medication helps control high blood pressure in patients with essential hypertension, stabilizing blood pressure and reducing the risk of cardiovascular diseases. It is also used to improve symptoms of heart failure and cardiac function in patients with left ventricular systolic dysfunction who require combination therapy with ACE inhibitors or have poor tolerance to ACE inhibitors. Therefore, it is effectively used for the treatment of hypertension and heart failure.

How to take

Adult dose

This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: Candesartan cilexetil 8 ∼ 16 mg orally once daily is recommended as the initial and maintenance dose. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled with this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, taking the patient's tolerability into consideration. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Pediatric patients: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure 3) Pediatric patients: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Precautions

This drug may cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so immediate discontinuation is required upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this drug. Patients with severely impaired liver function or specific hereditary diseases should also refrain from taking this drug. Elderly individuals, patients with hyperkalemia, and those with mildly impaired liver function should use this medication cautiously, particularly by regularly monitoring blood pressure and renal function. During treatment with this drug, side effects such as dizziness, back pain, and respiratory infections may occur, so any abnormal symptoms should be discussed with a healthcare provider. Heart failure patients may experience side effects such as low blood pressure, hyperkalemia, and worsening kidney function, thus requiring regular blood tests. If this drug is taken with other antihypertensive medications, the blood pressure-lowering effect may be enhanced, so it should be taken according to healthcare provider's instructions. Especially caution is needed when taken with potassium-sparing diuretics or potassium supplements, as blood potassium levels may become dangerously high. Dizziness may occur when driving or operating machinery, so caution is advised. In case of overdose, low blood pressure and dizziness may occur, requiring an immediate visit to a medical facility; this drug is not eliminated by hemodialysis. Keep out of the reach of children and do not transfer to other containers for safety.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
Show 76 more
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbances
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • dizziness
  • headache
  • intestinal vascular edema
  • nausea
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • rash
  • urticaria
  • pruritus
  • angioedema
  • myalgia
  • weakness
  • elevated creatine kinase
  • increased serum myoglobin levels
  • increased urinary myoglobin levels
  • joint pain
  • myalgia
  • low back pain
  • kidney dysfunction
  • acute kidney failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • memory loss
  • anorexia
  • increased appetite
  • tinnitus
  • taste disturbances
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly closed container to prevent air or moisture from entering. It is important to keep the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink, round, biconvex tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.